In Brief
An inflammatory environment threatens the stability of Foxp3 + Treg cells. Garg et al. show that by expressing the transcriptional regulator Blimp1, Treg cells resist the IL-6-driven loss of Foxp3 in inflamed tissues. Blimp1 prevents the methylation and reduced expression of Foxp3 through inhibition of the methyltransferase Dnmt3a.
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INTRODUCTION
Foxp3
+ Treg cells are either thymus derived (tTreg cells) or induced from conventional CD4 + T (Tconv) cells outside the thymus (pTreg cells) or can be generated in vitro (iTreg cells) (Abbas et al., 2013) . In an inflamed environment, such as the CNS during experimental autoimmune encephalomyelitis (EAE), pTreg cells cannot be generated and tTreg cells migrate to the CNS, become activated in a T cell receptor (TCR)-dependent manner, expand, and acquire suppressive Treg effector functions (Korn et al., 2007; O'Connor et al., 2007) . Even though tTreg cells are indispensable to control CNS inflammation (McGeachy et al., 2005) , little is known about their resilience to inflammation in the CNS. Epigenetic DNA marks are crucial determinants of Treg cell identity. Complete demethylation of the conserved non-coding sequence 2 (CNS2), also known as Treg cell-specific demethylated region (TSDR), in the first intron of the Foxp3 locus is required for optimal expression of Foxp3 (Floess et al., 2007) . Conversely, methylation of CNS2 results in the reduced transcription of Foxp3 and subsequent loss of Treg cell functionality. Notably, less demethylation of CNS2 in iTreg cells causes their instability compared to tTreg cells (Polansky et al., 2008) . While epigenetic manipulation is intensely explored to ''stabilize'' iTreg cells (also for therapeutic use), less is known about modifications of epigenetic DNA marks in tTreg cells. Interestingly, CNS2 demethylation in tTreg cells is already initiated during thymic development (Toker et al., 2013) , in a process that appears independent of the induction of Foxp3 (Ohkura et al., 2012) . Therefore, impaired DNA demethylation in tTreg cells might compromise their identity in spite of a fully mounted Foxp3-dependent transcriptional program.
Blimp1 is a zinc finger protein, which serves as a transcriptional regulator and is indispensable for the development of (legend continued on next page) plasma cells and fully functioning effector CD8 + T cells (Kallies et al., 2009; Rutishauser et al., 2009; Shapiro-Shelef et al., 2003) . In CD4 + T cells, Blimp1 limits follicular helper T cell differentiation (Choi et al., 2011) . Furthermore, Blimp1 transactivates Il10 and thereby drives the conversion of T helper 1 (Th1) and Th17 cells into type 1 regulatory T (Tr1) cells (Heinemann et al., 2014; Neumann et al., 2014) . Finally, Blimp1 has been identified to support a residency program of CD8 + T cells in non-lymphoid tissues (Mackay et al., 2016) . In Treg cells, Blimp1 cooperates with interferon regulatory factor 4 (IRF4) to establish a Treg cell effector program, including the expression of interleukin-10 (IL-10) and granzyme B in particular in non-lymphoid tissues (Cretney et al., 2011; Vasanthakumar et al., 2015) .
Here, we reveal a non-redundant function for Blimp1 in preserving the identity of Treg cells, particularly under conditions of an inflammatory challenge. IL-6 signaling induces and activates the DNA methylating enzyme Dnmt3a, which is mounted to distinct DNA sites in the absence of Blimp1, leading to CNS2 methylation and Foxp3 downregulation. Conversely, Blimp1 inhibits the upregulation of Dnmt3a, prevents methylation of CNS2 in the Foxp3 locus, and thereby maintains Treg cell identity and function. Consequently, Treg cell-specific loss of Blimp1 in an inflammatory environment results in the methylation of CNS2, loss of Foxp3 expression, and the acquisition of a proinflammatory T cell phenotype.
RESULTS
Treg Cells Show Stable Foxp3 Expression in the Inflamed CNS In Vivo
Strong inflammation can trigger the loss of Treg cell identity and acquisition of a proinflammatory phenotype in Treg cells (Zhou et al., 2009) . Consistent with earlier reports (Kim et al., 2017; Korn et al., 2007) , CNS Treg cells during EAE did not only express IL-10, but a fraction of them expressed proinflammatory cytokines, including IL-17 and interferon-g (IFN-g) ( Figure 1A ). In RNA sequencing (RNA-seq) analysis of Foxp3 (GFP) + Treg cells isolated from the spleen and CNS of EAE mice at the peak of disease, CNS Treg cells showed a downregulation of 507 genes and upregulation of 783 genes (>2-fold, p < 0.05) as compared with splenic Treg cells, together comprising a transcriptional signature of CNS Treg cells (Table S1 ). As expected, principal-component analysis (PCA) showed that splenic and CNS Treg cells grouped together in principal component 2 (PC2) and clearly separated from conventional CD4 + T cells isolated from the same organs ( Figure 1B) . Interestingly, however, principal component 1 (PC1) separated these populations according to the organ they were isolated from, indicating that the tissue controls significant parts of the transcriptional signature ( Figure 1B) . Notably, signature genes of Th1 and Th17 genes were upregulated in CNS Treg cells as compared to splenic Treg cells (Figures S1A and S1B) . Thus, at the site of inflammation, Treg cells appeared to be poised for proinflammatory effector programs. However, Foxp3 was maintained in CNS Treg cells and expressed in even higher amounts than in splenic Treg cells during disease ( Figure 1C ). Thus, we hypothesized that specific mechanisms must exist that preserve Treg cell identity in an inflamed environment.
CNS Treg Cells Express High Amounts of Blimp1 and Display an Effector Treg Cell Signature
Proinflammatory cytokines have been implicated both in the maintenance and loss of Treg cell identity (Koch et al., 2012; Overacre-Delgoffe et al., 2017) . To understand which pathways may have an impact on Treg cells during CNS inflammation, we performed gene set enrichment analyses in CNS versus splenic Treg cells. CNS Treg cells showed pronounced enrichment for IFN-g-, IL-12-, and IL-27-(but not IL-23, data not shown) induced genes, suggesting that CNS Treg cells can sense multiple inflammatory cytokines during inflammation ( Figure S1C ). Notably, Prdm1 (encoding Blimp1) was common to all three gene sets ( Figures 1D and 1E ). Blimp1 expression was higher in CNS Treg cells compared to splenic Treg cells, and effector Treg cell signature genes expressed in Blimp1 + versus Blimp1 À Treg cells (Cretney et al., 2011) were highly enriched in the transcriptional profile of CNS as compared to splenic Treg cells ( Figure 1F ). Using a Blimp1 (yellow fluorescent protein [YFP]) reporter mouse (Rutishauser et al., 2009) , n = 6 (mean ± SD) (F).
by the upregulation of inflammation sensing pathways, high expression of suppressive molecules, and the upregulation of Blimp1.
Blimp1 Is Maintained in CNS Treg Cells in a STAT1-Dependent Manner TCR-induced IRF4 expression has been shown to drive Blimp1 expression in both Treg cells and conventional T cells (Cretney et al., 2011; Krishnamoorthy et al., 2017; Man et al., 2013) . In addition, multiple cytokines in conjunction with TCR signaling have been shown to be able to induce Blimp1 expression through direct binding of signal transducer and activator of transcription (STAT) molecules to the Prdm1 locus (Cretney et al., 2011; Heinemann et al., 2014; Kwon et al., 2009; Xin et al., 2016) . Consistent with this notion, IL-10 and IL-21 (STAT3) and a number of inflammatory cytokines, including IFN-g (STAT1), IL-12 (STAT4), and IL-27 (STAT3) induced Blimp1 in cultured splenic Treg cells ( Figure 1H ). To identify inflammatory pathways involved in Blimp1 expression in Treg cells during autoimmune CNS inflammation, we generated mixed bone marrow chimeric mice containing wild-type bone marrow together with either STAT1-deficient, STAT3-deficient (T cell-specific conditional using Cd4 Cre) or STAT4-deficient bone marrow. After induction of EAE, Treg cells were sorted from the CNS and spleens of these chimeric mice at the peak of EAE and assessed for expression of Prdm1 (Blimp1) and its target Il10. When compared to the concomitant wild-type compartment, Prdm1 was not reduced in STAT3-deficient and STAT4-deficient Treg cells ( Figures  S2A and S2B) ; however, it was markedly decreased in STAT1-deficient Treg cells ( Figures 1I and 1J) 
Blimp1
DFoxp3 CNS Treg cells showed a significant downregulation of Foxp3 as compared to their wild-type counterparts ( Figure 3A ). Furthermore, they had lost IL-10 expression and acquired IL-17 production ( Figures 3B and 3C Figure 3D ). In total, we identified 342 genes upregulated (>2-fold, p < 0.05) and 409 genes downregulated (>2-fold, p > 0.05) in Blimp1 DFoxp3 CNS Treg cells, including reduced expression of known Blimp1 target genes, such as Il10 and Gzmb ( Figure 3E ; Table S2 ). Consistent with their increased production of IFN-g, Blimp1-deficient CNS Treg cells expressed higher amounts of Tbx21 (T-bet) ( Figures S3A and S3B ). In line with the reduced expression of Foxp3, genes normally suppressed by Foxp3 showed significant derepression in Blimp1 DFoxp3 CNS Treg cells ( Figure 3F ). In summary, Blimp1 Figure 6E ). In contrast, wild-type Treg cells kept the demethylated state of CNS2 in the Foxp3 locus ( Figure 6E ).
Antagonistic Control of CNS2 (TSDR) Methylation by Blimp1 and IL-6-STAT3 through Dnmt3a
The methylation status of the Foxp3 CNS2 has previously been shown to be controlled by the ten-eleven-translocation (Tet) See also Figure S3 and Table S2 . Runx1 (2) Runx1 (1) Runx1(3)
Batf (2) Nfkb ( (legend continued on next page) family of enzymes, which contribute to its demethylation (Yue et al., 2016) , and DNA-methyltranferases (Dnmts), which oppose the activity of Tet enzymes and methylate CpG islands in the CNS2 (Feng et al., 2014; Josefowicz et al., 2009 Figure 6G ). Thus, our data indicated that in an inflammatory environment, Dnmt3a was suppressed by Blimp1. Inflammatory signals have been associated with the loss of Treg cell identity (Zhou et al., 2009) , and IL-6 in particular has been shown to drive the expression of inflammatory cytokines in Foxp3 + Treg cells (Yang et al., 2008) . We hypothesized that IL-6 may contribute to the loss of Foxp3 observed in Blimp1
DFoxp3 Treg cells. Therefore, we interrogated the transcriptome of CNS Treg cells versus splenic Treg cells of EAE mice for the enrichment of IL-6 target genes. We found that IL-6 target genes were enriched in the transcriptome of CNS Treg cells as compared to splenic Treg cells (Figure 7A) , suggesting that CNS Treg cells indeed sensed IL-6. We also hypothesized that IL-6 induced the expression of Dnmt3a, which would contribute to the methylation of the Treg cells (Dnmt3a wt/wt 3 Mx1 Cre) ( Figure 7D ). In addition, the IL-6-induced loss of Foxp3 in Blimp1 À Treg cells was rescued when Dnmt3a was pharmacologically blocked using the inhibitor SGI-1027 ( Figures 7E and S5C) . Thus, the loss of Dnmt3a by genetic ablation or pharmacologic inhibition protected 
DISCUSSION
Treg cells have been shown to be remarkably stable and can preserve their identity and function in a range of conditions both during steady state and in inflammation (Rubtsov et al., 2010) . A variety of signals, including costimulatory signals, were identified to contribute to the stability of Treg cells (DuPage et al., 2015) . However, Treg cells lose their identity upon the loss of Foxp3 expression (Williams and Rudensky, 2007) , and the idea of lineage stability of Treg cells has been challenged in severe inflammation (Zhou et al., 2009 (Koch et al., 2012) . This is consistent with our data, which show that STAT1 signaling in Treg cells is required for the expression of Blimp1, a major regulator of IL-10 in Treg cells (Cretney et al., 2011) , and is a factor required to maintain Foxp3 expression as we show here. Although STAT3, STAT4, and STAT5 regulate Blimp1 expression in conventional T cells (Heinemann et al., 2014; Kwon et al., 2009; Neumann et al., 2014; Xin et al., 2016) , STAT1 has been shown to directly transactivate the promoter of Blimp1 in B cells (Chen et al., 2016) . Whether STAT1 activation in Treg cells is dependent on the canonical interferon-induced pathway or non-canonical STAT1 activation by TLR signals (Luu et al., 2014) remains to be determined. Notably, although IL-10 derived from conventional T cells is required to induce full suppressive effector functions in Treg cells (Chaudhry et al., 2011; Heinemann et al., 2014) , genetic ablation of the IL-10 receptor (Il10ra) in Treg cells is not associated with a loss of Foxp3 expression (Chaudhry et al., 2011) . Therefore, our data support the idea that proinflammatory (rather than anti-inflammatory) cytokine signals appear to initiate a feedback loop that maintains Treg cell identity and function in an inflammatory environment. Blimp1-mediated maintenance of Treg cell stability becomes indispensable under ''inflammatory pressure.'' Interestingly, it has previously been reported in a fate mapping system that a subset of Foxp3 + Treg cells loses Foxp3 expression and becomes proinflammatory (Bailey-Bucktrout et al., 2013) , and it is intriguing to speculate that these are Foxp3 + Treg cells that fail to sufficiently upregulate Blimp1. In fact, in two recently published studies, lower expression of Foxp3 in Blimp1-deficient Treg cells was measured but not further explored (Bankoti et al., 2017; Ogawa et al., 2018 ). Yet, a stronger proliferation of Blimp1-deficient as compared to Blimp1-sufficient Treg cells was observed, which is consistent with lower levels of Foxp3 in Blimp-deficient Treg cells (Bankoti et al., 2017) . Here, our data provide a mechanistic underpinning for cytokine-guided stability or plasticity of Treg cells by linking cytokine signaling pathways to the Blimp1-mediated transcriptional modulation of the enzymatic machinery that controls DNA methylation in cis regulatory elements of the Foxp3 locus. Tet family enzymes and Dnmts are opposing players in demethylating or methylating CpG islands within DNA elements in immune cells and nonimmune cells (Tang et al., 2015) . Unmethylated DNA is de novo methylated by Dnmt3a, whereas Dnmt1 is responsible for the maintenance of pre-existing methylation (Lyko, 2018 In Treg cells, CNS2 acts as a sensor for IL-2 whose downstream signal transducer STAT5 binds to CNS2. The susceptibility of this sensor to STAT5 binding is, in turn, controlled by its methylation status (Feng et al., 2014) . IL-6-STAT3-mediated Dnmt3a activation promotes CNS2 methylation and, thus, likely abrogates STAT5 binding, resulting in reduced Foxp3 transcription under limiting IL-2 conditions (Feng et al., 2014) . Our data suggest that there might be a direct antagonistic control of Dnmt3a by STAT3 versus Blimp1 (see Figure S5D ). Our model is not mutually exclusive with the idea that some genes that are suppressed by Foxp3 (Zhou et al., 2008) are also directly (transcriptionally) suppressed by Blimp1. For instance, direct suppression of Il17a has recently been described in Helios
À
RORgt
+ pTregs in the intestine (Ogawa et al., 2018). However, in autoimmune CNS inflammation, pTreg cells are not induced (Josefowicz et al., 2012; Korn et al., 2007) , and the ''toxic gain'' of IL-17 production, which we observed in Blimp1-deficient CNS Treg cells, only represents a minor contribution to the overall production of IL-17 in the CNS of EAE mice. Therefore, we conclude that the global loss of Treg cell identity through the loss of Foxp3 expression as a consequence of a lack of Blimp1 in CNS Treg cells is responsible for the uncontrolled inflammatory phenotype that we noticed in Blimp1 DFoxp3 mice. In future studies, it will have to be seen how the Blimp1-mediated transcriptional regulation of Dnmt3a and its recruitment to DNA loci determine a hierarchy of epigenetic regulation of distinct genetic loci in Treg cells. In addition, the activation of the IL-6-STAT3 pathway has many downstream targets, and specific modulators of that pathway that result in enhanced expression and function of Dnmt3a in Treg cells need to be identified.
In summary, we have identified a mechanism that antagonizes IL-6-STAT3-induced abrogation of Foxp3 in tTreg cells. This pathway is Blimp1 dependent and supports Treg cell identity at sites of inflammation by keeping CNS2 in a demethylated state, thus allowing the continuous expression of Foxp3 and maintenance of suppressive function. The opposing activities of STAT3 and Blimp1 converging on Dnmt3a will be interesting to further explore for druggable targets that could be used to stabilize Treg cells in autoimmunity and destabilize them for the treatment of cancer.
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EXPERIMENTAL MODELS AND SUBJECT DETAILS Animals
Prdm1.yfp (Blimp1 (YFP)) reporter mice (Rutishauser et al., 2009) , Rag1 À/À mice (Mombaerts et al., 1992) , Il12rb2 À/À mice (Wu et al., 2000) , WSX (Il27r) À/À mice (Yoshida et al., 2001) , Prdm1 flox/flox (Blimp1 flox/flox ) (Shapiro-Shelef et al., 2003) , Il6 À/À mice (Kopf et al., 1994) , and congenic CD45.1 mice (Shen et al., 1985) were obtained from Jackson Laboratory. Treg conditional Blimp1-deficient mice did not develop spontaneous autoimmunity. DEREG mice (Lahl et al., 2007) were kindly provided by T. Sparwasser (Twincore, Hannover Medical School, Hannover, Germany). Stat3 flox/flox (Stat3 tm2Aki ) mice (Takeda et al., 1998) were a gift of F. Greten (Institute for Tumor Biology and Experimental Therapy, Georg-Speyer Haus, Frankfurt). Stat1 À/À mice (Durbin et al., 1996) were kindly provided by S. Kemmner (U. Heemann, Department of Nephrology, Technical University (TU) Munich). Stat4 À/À mice (Kaplan et al., 1996) were obtained from M. Lö hning (Department of Rheumatology and Clinical Immunology, Charité -Universitä tsmedizin Berlin). To generate mice with cell type-specific excision of loxP-flanked cassettes, mice with loxP-flanked alleles were bred with CD4 Cre (Tg(Cd4-cre) 1Cwi ) mice (Lee et al., 2001 ) (from Jackson Laboratory) or with Foxp3
Cre mice (Wing et al., 2008) obtained on the C57BL/6 background from M. Oukka (Department of Pediatrics, University of Washington, USA). Dnmt3a flox/flox mice were originally obtained from Dr. En Li (Novartis) (Okano et al., 1999) . Dnmt3a À/À mice were generated by breeding Dnmt3a flox/flox mice with Mx1-Cre mice (from The Jackson Laboratory). Deletion of the floxed Dnmt3a allele was induced by intraperitoneal injection of 250 mg polyI:C (Sigma, P1530) four times every other day. CD90.1 mice were provided by V. Buchholz (Institute for Medical Microbiology, Immunology and Hygiene, TU Munich). Rosa26 RFP (Luche et al., 2007) x Foxp3 Cre mice were kindly provided by Tobias Bopp (Institute of Immunology, Johannes Gutenberg University, Mainz). Il10 flox/flox x Foxp3 Cre mice were generated in WEHI by crossing Il10 flox/flox mice (Roers et al., 2004) to Foxp3 Cre mice , both obtained from Jackson Laboratory. All mouse strains were on pure C57BL/6 background. Animals were kept in a specific pathogen-free facility at the Technical University of Munich or at the Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. All experimental protocols were approved by the standing committee for experimentation with laboratory animals of the Bavarian state authorities or the animal ethics committee of the Walter and Eliza Hall Institute and carried out in accordance with the corresponding guidelines. 6-10 week old age and sex-matched mice were used for all experiments, except for those involving methylation analysis (see Method details), in which only male mice were used. 
METHOD DETAILS
Generation of mixed bone marrow chimeras For generation of mixed bone marrow chimeras, Rag1 À/À mice at 6-8 weeks of age were used as recipients. The mice were irradiated at a total dose of 7 Gray with two times 3.5 Gray 3h apart. 5-10 3 10 6 donor bone marrow cells depleted of CD90.2 + cells were injected i.v. into irradiated Rag1 À/À recipients within 16-20 h post irradiation. The reconstituted mice were maintained on antibiotic water (Enrofloxacin, Bayer, 0.1 mg/ml) for 2 weeks after transplantation. The reconstitution of the hematopoietic compartment was checked 5-6 weeks post cell transfer in peripheral blood.
Induction of EAE EAE was induced by subcutaneous immunization in the base of tail with 200 mg of MOG35-55 (MEVGWYRSPFSRVVHLYRNGK; Auspep, Tullamarine, Australia) in complete Freund's adjuvant containing 500 mg Mycobacterium tuberculosis H37Ra (Difco, Detroit, MI)) per mouse plus intravenous injection (i.v.) of 200 ng pertussis toxin (Sigma-Aldrich) on days 0 and 2 after immunization. Disease progress and severity were assessed as described before (Korn et al., 2008) . The peak of disease was typically between 15 and 20 days post immunization. 
Preparation of mononuclear cells from the central nervous system (CNS)
Mice were perfused through the left cardiac ventricle with phosphate-buffered saline. The forebrain and cerebellum were dissected and spinal cords flushed out with phosphate-buffered saline by hydrostatic pressure. CNS tissue was cut into pieces and digested with 2.5 mg/ml collagenase D (Roche Diagnostics) and 1 mg/ml DNaseI (Roche Diagnostics) at 37 C for 45 min. Mononuclear cells were isolated by passing the CNS tissue through a 70 mm cell strainer (BD Biosciences), followed by a percoll gradient (70%/37%) centrifugation. The cells were removed from the interphase, washed and resuspended in culture medium for further analysis. Cell culture 10% FCS containing DMEM supplemented with 5 X 10 À5 M b-mercaptoethanol, 1 mM sodium pyruvate, non-essential amino acids, L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin was used as culture medium. Cells were cultured in 96 well U bottom plates (Corning) at 37 C/5% CO 2 . 0. 
Preparation of peripheral T cells
Antibodies and flow cytometry
Cell suspensions from lymphoid organs were stained with fluorochrome-conjugated anti-mouse CD4 (RM4-5), CD25 (PC61.5), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD62L (MEL-14), CD90.1 (OX-7), GITR (CD357) (DTA-1), Ki67 (16A8), CD126 (D7715A7) and KLRG1 (2F1), which were purchased from either Biolegend, eBioscience or BD Biosciences. For dead cell exclusion, LIVE/ DEAD â fixable Near-IR stain kit (Invitrogen) was used. For intracellular staining, Foxp3 staining kit (eBioscience) was used for Foxp3 (FKJ-16 s), IL-10 (JES5-16E3), IL-17 (TC11-18H10), IFN-g (XMG1.2). For cytokine stainings, cells were stimulated in culture medium containing phorbol 12-myristate 13-acetate (PMA, 20 ng/ml, Sigma), ionomycin (1 mg/ml, Sigma), and monensin (GolgiStop 1 ml/ml, BD Biosciences) at 37 C/5% CO 2 for 4 h. Flow cytometric analysis was performed on a CyAn ADP flow cytometer (Beckman Coulter) or a FACS Aria III (BD Biosciences), and flow cytometric data were analyzed using FlowJo software (Tree Star).
Quantitative PCR
Total RNA was isolated from purified Treg cells and Tconv cells with RNAeasy Plus micro kit (QIAGEN). The isolated RNA was transcribed into cDNA using the TaqMan Reverse Transcription Reagents Kit (Life Technologies) according to the manufacturer's instructions. Probes were purchased from Life Technologies and the assays were performed on 96-well reaction plates (Life Technologies). The real time PCR was performed on StepOnePlus system (Life Technologies). In all experiments Actb was used as reference gene to normalize gene expression.
RNA-seq
Total RNA was isolated from purified Treg cells and Tconv cells with RNAeasy Plus micro kit (QIAGEN). Quality and integrity of total RNA was controlled on Agilent Technologies 2100 Bioanalyzer (Agilent Technologies). RNaseq analysis: library preparation for bulk 3 0 -sequencing of poly(A)-RNA was done as described previously (Parekh et al., 2016) . Briefly, barcoded cDNA of each sample was generated with a Maxima RT polymerase (Thermo Fisher) using oligo-dT primer containing barcodes, unique molecular identifiers (UMIs) and an adaptor. 5 0 ends of the cDNAs were extended by a template switch oligo (TSO) and full-length cDNA was amplified with primers binding to the TSO-site and the adaptor. cDNA was tagmented with the Nextera XT kit (Illumina) and 3 0 end-fragments finally amplified using primers with Illumina P5 and P7 overhangs. In comparison to Parekh et al. (2016) , the P5 and P7 sites were exchanged to allow sequencing of the cDNA in read1 and barcodes and UMIs in read2 to achieve a better cluster recognition. The library was sequenced on a NextSeq 500 (Illumina) with 75 cycles for the cDNA in read1 and 16 cycles for the barcodes and UMIs in read2. Data was processed using the published Drop-seq pipeline (v1.0) to generate sample-and gene-wise UMI tables (Macosko et al., 2015) . Reference genome (GRCm38) was used for alignment. Transcript and gene definitions were used according to the ENSEMBL annotation release 75. Differential gene expression was calculated using the DESeq2 package (v1.18.0) (Love et al., 2014) . We focused on genes with less than 5% probability to be false positive (p-adjusted < 0.05). When necessary, log2 transformation was realized using ''rlog'' function from Deseq2.
For gene set enrichment analysis (GSEA) a ranked list of the fold change of RNA-seq read values of the samples to be compared was calculated. The java GSEA Desktop Application v2.2.1, was used in conjunction with the Molecular Signatures Database v45.1 to run the analysis. We always used sample label (phenotype) permutation and thus applied an FDR of 0.25.
ChIP-seq
To assess Blimp1 binding at specific gene loci, we interrogated the ChIP-seq data published earlier (Mackay et al., 2016) . Here, CD8 + T cells from Blimp1-Bio mice carrying a biotin acceptor sequence at the carboxyl terminus of Blimp1, which was biotinylated in vivo by coexpression of the Escherichia coli biotin ligase BirA from the Rosa26
BirA allele, were stimulated in vitro with anti-CD3 and anti-CD28 in the presence of IL-2 and IL-12 (Mackay et al., 2016) . To obtain STAT3 ChIP-seq data, murine naive CD4 + T cells were stimulated with anti-CD3 and anti-CD28 in the presence of IL-6 (Hirahara et al., 2015) . ChIP-seq tracks were generated using Integrated genome browser (Robinson et al., 2011) .
ATAC-seq ATAC-seq was done as described by Corces et al., (2017) . Briefly, 50000 cells (viability > 90%) were pelleted (500 rcf., 4 C, 5 min) and re-suspended in ATAC Resuspension Buffer (10mM Tris-HCl pH 7.4, 10mM NaCl, 3mM MgCl 2 ) supplemented with 0.1% NP40, 0.1% Tween-20 and 0.01% digitonin for lysis, incubated on ice for 3 min and then 1ml of ATAC Resuspension Buffer supplemented only with 0.1% Tween-20 was added and spun at 500 g for 10 min at 4 C to collect nuclei. Nuclei were subsequently re-suspended in 50 ml Transposase reaction containing 25mL 2x tagmentation buffer, 5.25 ml water, 2.5 ml Tn5 Transposase (Illumina Nextera DNA Library Preparation Kit, cat. FC-121-1030), 16.5 ml PBS, 0.25 ml of 2% digitonin (Promega, G9441), 0.5 ml of 10% Tween-20. Reactions were incubated for 30 min at 37 C in a thermomixer shaking at 900 rpm and DNA purified using QIAGEN PCR clean-up MinElute kit (QIAGEN). The transposed DNA was subsequently amplified in 50ml reactions with custom primers as described (Buenrostro et al., 2013) . After 4 cycles libraries were then monitored with qPCR: 5 ml PCR sample in a 15 ml reaction with the same primers. qPCR output was monitored for the DRN; 0.25 DRN cycle number was used to estimate the number of additional cycles of the PCR reaction needed for the remaining PCR samples. Amplified libraries were purified with the QIAGEN PCR clean-up MinElute kit (QIAGEN) and size selected for fragments less than 600 bp using the Agencourt AMPure XP beads (Beckman Coulter). Libraries were quality controlled by Qubit and Agilent DNA Bioanalyzer analysis. Deep sequencing was performed on a HiSeq 1500 system according to the standard Illumina protocol for 50bp single-end reads.
ATAC-seq reads were aligned to the mouse genome mm10 using Bowtie (Langmead, 2010) with options ''-q -n 2-best-chunkmbs 2000 -p 32 -S.'' ATAC peaks over Input background were identified using Homer (Heinz et al., 2010) findPeaks.pl with option ''-style factor.'' Peaks from all samples were merged using mergePeaks resulting in a unified Peak set. The peak list was filtered for promoter-associated peaks (distance to TSS < 1000bp) with bedtools. Raw ATAC coverage counts were then calculated with annotatePeaks within 500bp across the peak centers. Differential ATAC peaks were determined with the DESeq2 result function and filtered for padj < 0.05. Genomic feature annotation of ATAC-seq peaks was done using annotatePeaks. Transcription factor motif prediction was done with Homer findMotifsGenome.pl.
Methylation analysis
For all methylation analyses, cells from male mice were used. Bisulfite-converted DNA was prepared from FACS-sorted Treg cells and Tconv cells according to the manufacturer's instructions (EZ DNA Methylation-Direct Kit, Zymo Research). Pyrosequencing was performed as described previously (Yang et al., 2016) . Amplification and sequencing of the Treg cell-specific demethylated region (TSDR) (chromosome position X:7583986-7584149), the Foxp3 promoter (chromosome position X:7579550-7579731), a region in 
. The indicated chromosome positions refer to genome assembly GRCm38.p5.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical evaluations of cell frequency measurements, cell numbers, mRNA amounts, and protein levels were performed with the unpaired Student's t test when two populations were compared. Two-tailed p values < 0.05 were considered significant. Multiple comparisons were performed with one-way ANOVA or two-way ANOVA followed by post hoc multiple comparisons tests as indicated in the legends to the figures. EAE scores between groups were analyzed as disease burden per individual day with one-way-ANOVA and post hoc test as indicated. Survival curve was calculated using Kaplan-Meier analysis and the p values were analyzed with log-rank test (Mantel-Cox). A p value of p < 0.05 was considered significant. Calculations were performed using Graph Pad Prism v5.0 (Graph-Pad software).
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon request. (A) Blimp1-ChIP-seq-, STAT3 ChIP-seq-, and ATAC-seq analyses on the Dnmt3a and Stat3 loci. STAT3 ChIP-seq was performed on IL-6 treated CD4 + T cells (Hirahara et al., 2015) . Blimp1 ChIP-seq was performed on CD8 + T cells (Mackay et al., 2016; Minnich et al., 2016 -naïve T cells were sorted from spleen and lymph nodes of Foxp3 (GFP) reporter mice. The naïve T cells were cultured with anti-CD3 and anti-CD28 dynabeads in the presence of IL-2 and TGF-β (5ng/ml) for five days. On day 5, the induced Foxp3 (GFP) + Treg cells were FACS-sorted and restimulated with anti-CD3 and anti-CD28 dynabeads in the presence of either IL-2 containing medium alone, or additional TGF-β (5ng/ml) or additional SGI-1027 (at indicated concentrations) for four days. On day 4 of restimulation, the cultures were analyzed for viability and Foxp3 expression using flow cytometry. (D) Foxp3 expression is regulated by epigenetic modification of the Foxp3 locus. Methylation of CNS2 (TSDR) results in reduced expression of Foxp3. Here, we propose that the methyltransferase Dnmt3a is induced by IL-6 in a STAT3-dependent manner. In contrast, Blimp1 represses Dnmt3a transcription by directly binding to the Dnmt3a locus and by this means counteracts the IL-6 driven reduction of Foxp3 expression in Treg cells. In addition, Blimp1 represses the transcription of Stat3. Thus, Blimp1 is fundamental for the identity (and function) of Treg cells -a function that only unmasks in the face of inflammation.
